These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10905688)

  • 1. Interactive discussion on chemotherapy-related adverse events.
    Adams VR; Lyman GH
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
    Stull DM; Bilmes R; Kim H; Fichtl R
    Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloid growth factors.
    Crawford J; Armitage J; Balducci L; Bennett C; Blayney DW; Cataland SR; Dale DC; Demetri GD; Erba HP; Foran J; Freifeld AG; Goemann M; Heaney ML; Htoy S; Hudock S; Kloth DD; Kuter DJ; Lyman GH; Michaud LB; Miyata SC; Tallman MS; Vadhan-Raj S; Westervelt P; Wong MK;
    J Natl Compr Canc Netw; 2009 Jan; 7(1):64-83. PubMed ID: 19176207
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
    Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
    Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic and humanistic impact of adverse events associated with CSFs.
    Gibson GA
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):118S-120S. PubMed ID: 10905687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic growth factors for chemotherapy-induced neutropenia.
    Yalçin S
    Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 11. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.
    Gómez Raposo C; Pinto Marín A; González Barón M
    Clin Transl Oncol; 2006 Oct; 8(10):729-34. PubMed ID: 17074671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth factor frenzy.
    Quesenberry PJ
    Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 15. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.
    Freyer G; Ligneau B; Trillet-Lenoir V
    Int J Antimicrob Agents; 1998 Apr; 10(1):3-9. PubMed ID: 9624538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-stimulating factor use in the context of refined risk and benefit assessments.
    Crawford J
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):9-10. PubMed ID: 16736982
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemopoietic growth factors and childhood cancer.
    Hann IM
    Eur J Cancer; 1995; 31A(9):1476-8. PubMed ID: 7577075
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors and empiric therapy with antibiotics: should they be used concurrently?
    Schimpff SC
    Ann Intern Med; 1994 Oct; 121(7):538-40. PubMed ID: 7520677
    [No Abstract]   [Full Text] [Related]  

  • 20. Colony-stimulating factors stimulate some treatments, continue to evolve.
    Volkers N
    J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.